Total Payments
$97,847
2021 Payments
$3,655
Companies
2
Transactions
123
Medicare Patients
2,795
Medicare Billing
$67,365
Payment Breakdown by Category
Other$84,750 (86.6%)
Consulting$8,048 (8.2%)
Travel$3,783 (3.9%)
Food & Beverage$1,234 (1.3%)
Education$33.33 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $84,750 | 70 | 86.6% |
| Consulting Fee | $8,048 | 7 | 8.2% |
| Travel and Lodging | $3,783 | 25 | 3.9% |
| Food and Beverage | $1,234 | 18 | 1.3% |
| Education | $33.33 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $97,728 | 122 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $118.81 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $3,655 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($3,655) |
| 2020 | $1,830 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($1,830) |
| 2019 | $18,845 | 22 | Boehringer Ingelheim Pharmaceuticals, Inc. ($18,726) |
| 2018 | $43,495 | 55 | Boehringer Ingelheim Pharmaceuticals, Inc. ($43,495) |
| 2017 | $30,023 | 38 | Boehringer Ingelheim Pharmaceuticals, Inc. ($30,023) |
All Payment Transactions
123 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/16/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $645.00 | General |
| 08/31/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Consulting Fee | Cash or cash equivalent | $1,075.00 | General |
| Category: RESPIRATORY | ||||||
| 05/25/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $645.00 | General |
| 05/04/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $645.00 | General |
| 04/27/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $645.00 | General |
| 12/28/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $610.00 | General |
| 07/28/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $610.00 | General |
| 02/25/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $610.00 | General |
| 12/12/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,230.00 | General |
| 12/05/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $32.48 | General |
| 10/02/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $610.00 | General |
| 09/10/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $610.00 | General |
| 09/03/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $610.00 | General |
| 09/03/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Education | In-kind items and services | $14.90 | General |
| Category: RESPIRATORY | ||||||
| 08/19/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $610.00 | General |
| 07/23/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $118.81 | General |
| Category: Respiratory | ||||||
| 07/11/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,850.00 | General |
| 07/11/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,925.00 | General |
| 07/03/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $433.12 | General |
| 07/03/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $47.76 | General |
| 06/24/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $133.28 | General |
| 06/21/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,230.00 | General |
| 06/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $24.36 | General |
| 04/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $610.00 | General |
| 04/15/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $610.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 11 | 516 | 535 | $86,467 | $12,617 |
| 2021 | 12 | 1,210 | 1,310 | $215,053 | $29,553 |
| 2020 | 11 | 1,069 | 1,146 | $172,864 | $25,195 |
Total Patients
2,795
Total Services
2,991
Medicare Billing
$67,365
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 41 | 46 | $7,216 | $3,069 | 42.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 32 | $7,840 | $2,519 | 32.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $5,700 | $1,823 | 32.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $4,550 | $1,141 | 25.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 103 | 103 | $25,430 | $926.82 | 3.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 15 | 16 | $2,080 | $773.37 | 37.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 116 | 116 | $4,098 | $772.16 | 18.8% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 104 | 106 | $14,425 | $631.83 | 4.4% |
| 94618 | Test for exercise-induced lung stress | Facility | 2022 | 31 | 31 | $3,760 | $465.14 | 12.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 44 | 44 | $10,600 | $353.92 | 3.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 16 | 16 | $768.00 | $141.12 | 18.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 60 | 86 | $13,440 | $6,364 | 47.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 45 | 71 | $17,635 | $5,645 | 32.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 47 | 49 | $16,708 | $5,114 | 30.6% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2021 | 252 | 259 | $66,440 | $2,278 | 3.4% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 287 | 295 | $8,423 | $1,921 | 22.8% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2021 | 273 | 294 | $41,022 | $1,750 | 4.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 11 | $5,305 | $1,694 | 31.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 21 | 26 | $4,486 | $1,438 | 32.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 12 | 12 | $2,816 | $1,262 | 44.8% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 118 | 120 | $30,772 | $909.42 | 3.0% |
| 94618 | Test for exercise-induced lung stress | Facility | 2021 | 51 | 53 | $6,731 | $872.82 | 13.0% |
| 94727 | Determination of lung volumes using gas dilution or washout | Facility | 2021 | 33 | 34 | $1,275 | $305.60 | 24.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 50 | 83 | $18,243 | $6,799 | 37.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 63 | 63 | $18,531 | $6,748 | 36.4% |
About Dr. Harold Barkman, M.D
Dr. Harold Barkman, M.D is a Critical Care Medicine healthcare provider based in Kansas City, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801980438.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harold Barkman, M.D has received a total of $97,847 in payments from pharmaceutical and medical device companies, with $3,655 received in 2021. These payments were reported across 123 transactions from 2 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($84,750).
As a Medicare-enrolled provider, Barkman has provided services to 2,795 Medicare beneficiaries, totaling 2,991 services with total Medicare billing of $67,365. Data is available for 3 years (2020–2022), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Kansas City, KS
- Active Since 10/03/2006
- Last Updated 06/13/2019
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1801980438
Products in Payments
- STIOLTO RESPIMAT (Drug) $2,620
- SPIRIVA (Drug) $674.69
- FASENRA (Drug) $118.81
- SPIRIVA RESPIMAT (Drug) $28.79
- STIOLTO (Drug) $14.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Kansas City
Dr. Mario Castro, Md, MD
Critical Care Medicine — Payments: $2.3M
Critical Care Medicine $2.3M
Matthew Sharpe, M.d, M.D
Critical Care Medicine — Payments: $423,976
Critical Care Medicine $423,976
Dr. Matthew Aboudara, M.d, M.D
Critical Care Medicine — Payments: $27,642
Critical Care Medicine $27,642
Dr. Robert Winfield, Md, MD
Critical Care Medicine — Payments: $12,986
Critical Care Medicine $12,986
Heath Latham, M.d, M.D
Critical Care Medicine — Payments: $9,676
Critical Care Medicine $9,676
Timothy Williamson, M.d, M.D
Critical Care Medicine — Payments: $8,096
Critical Care Medicine $8,096